Benzinga··PrnewswireRoche Expands Mass Spectrometry Diagnostics with FDA's 'Moderate Complexity' Approval
Roche's Ionify® steroid assays receive FDA's moderate complexity designation, expanding access to mass spectrometry-based hormone testing across routine clinical laboratories.
RHHBYFDA approvalmass spectrometry